Related Experiment Video
Updated: May 27, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Iron in pregnancy: How do we secure an appropriate iron status in the mother and child?
1Departments of Clinical Biochemistry and Obstetrics, Næstved Hospital, Næstved, Denmark. nils.mil@dadlnet.dk
Insights
Preventing iron deficiency in pregnant women is crucial for fetal development and infant health. Tailored iron supplementation based on ferritin levels, rather than general prophylaxis, is recommended in affluent societies.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Nutritional Science
Background:
- Iron deficiency and iron deficiency anemia (IDA) in pregnancy pose risks for preterm birth, low birth weight, and impaired infant neurodevelopment.
- Increased iron requirements during pregnancy, particularly in the third trimester, often exceed dietary intake.
- A significant percentage of women enter pregnancy with inadequate iron stores, compromising fetal health.
Purpose of the Study:
- To highlight the importance of preventing iron deficiency in pregnant women to ensure optimal fetal iron status.
- To review current recommendations for iron supplementation during pregnancy.
- To advocate for individualized iron prophylaxis based on ferritin levels.
Main Methods:
- Review of existing literature on iron metabolism during pregnancy and the impact of deficiency.
- Analysis of dietary iron intake patterns in Scandinavian women.
- Evaluation of the efficacy of general versus individualized iron supplementation strategies.
Main Results:
- Over 90% of Scandinavian women have suboptimal dietary iron intake.
- Approximately 40% of non-pregnant women have low ferritin levels, indicating poor iron status for pregnancy.
- Only 15-20% of women achieve adequate iron reserves (≥500 mg) at conception.
Conclusions:
- Iron supplementation during pregnancy effectively reduces IDA prevalence.
- General low-dose iron prophylaxis is a strategy in Europe, but individualized prophylaxis is preferred in affluent societies.
- Specific ferritin-based guidelines for iron supplementation ensure adequate iron status throughout pregnancy.
Abstract:
Iron deficiency and iron deficiency anemia (IDA) during pregnancy are risk factors for preterm delivery, prematurity, and small for gestational age birth weight. Iron deficiency has a negative effect on intelligence and behavioral development in the infant. It is essential to prevent iron deficiency in the fetus by preventing iron deficiency in the pregnant woman. The requirements for absorbed iron increase during pregnancy from ∼1.0 mg/day in the first trimester to 7.5 mg/day in the third trimester. More than 90% of Scandinavian women of reproductive age have a dietary iron intake below the recommended 15 mg/day. Among nonpregnant women of reproductive age, ∼40% have plasma ferritin ≤30 μg/l, i.e. an unfavorable iron status with respect to pregnancy. An adequate iron status during pregnancy implies body iron reserves ≥500 mg at conception, but only 15-20% of women have iron reserves of such a magnitude. Iron supplements during pregnancy reduce the prevalence of IDA. In Europe, IDA can be prevented by a general low-dose iron prophylaxis of 30-40 mg ferrous iron taken between meals from early pregnancy to delivery. In affluent societies, individual iron prophylaxis tailored by the ferritin concentration should be preferred to general prophylaxis. Suggested guidelines are: ferritin >70 μg/l, no iron supplements; ferritin 31-70 μg/l, 30-40 mg ferrous iron per day, and ferritin ≤30 μg/l, 60-80 mg ferrous iron per day. In women with ferritin <15 μg/l, i.e. depleted iron reserves and possible IDA, therapeutic doses of 100 mg ferrous iron per day should be advised.
Related Concept Videos
Rh Blood Group
The Periodic Table and Organismal Elements
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The Early Endosome: Endocytosis of Transferrin

